Evidence map›Paper›PMID 22904086›Full record

ArticleNucleic acids research2012

Antisense morpholino targeting just upstream from a poly(A) tail junction of maternal mRNA removes the tail and inhibits translation.

Tadashi Wada, Masatoshi Hara, Takuya Taneda, Cao Qingfu, Ryouhei Takata, Kanako Moro, Kei Takeda, Takeo Kishimoto, Hiroshi Handa

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Self-transfecting GMO-PMO chimera targetingMolecular therapy. Nucleic acids · 2023
    Article
  3. Using Morpholinos to Control Gene Expression.Current protocols in nucleic acid chemistry · 2017
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tadashi WadaDivision of Molecular and Cellular Biology, Department of Supramolecular Biology, Graduate School of Nanobioscience, Yokohama City University, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan. tawada@tsurumi.yokohama-cu.ac.jp
Masatoshi Hara
Takuya Taneda
Cao Qingfu
Ryouhei Takata
Kanako Moro
Kei Takeda
Takeo Kishimoto
Hiroshi Handa
Yokohama City University · JPTokyo Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene downregulation by antisense morpholino oligonucleotides (MOs) is achieved by either hybridization around the translation initiation codon or by targeting the splice donor site. In the present study, an antisense MO method is introduced that uses a 25-mer MO against a region at least 40-nt upstream from a poly(A) tail junction in the 3'-untranslated region (UTR) of maternal mRNA. The MO removed the poly(A) tail and blocked zebrafish cdk9 (zcdk9) mRNA translation, showing functional mimicry between miRNA and MO. A PCR-based assay revealed MO-mediated specific poly(A) tail removal of zebrafish mRNAs, including those for cyclin B1, cyclin B2 and tbp. The MO activity targeting cyclins A and B mRNAs was validated in unfertilized starfish oocytes and eggs. The MO removed the elongated poly(A) tail from maternal matured mRNA. This antisense method introduces a new application for the targeted downregulation of maternal mRNAs in animal oocytes, eggs and early embryos.

Indexed as

Gene Expression Regulation3' Untranslated RegionsAnimalsAsterinaCyclin BCyclin-Dependent Kinase 9Down-RegulationGene Knockdown TechniquesInjectionsMorpholinosOligonucleotides, AntisenseOocytesPoly APolyadenylationProtein BiosynthesisRNA, Messenger, Stored3' Untranslated RegionsCdk9 protein, zebrafishCyclin BCyclin-Dependent Kinase 9MorpholinosOligonucleotides, AntisensePoly ARNA, Messenger, StoredZebrafish Proteins

Identifiers

PMID22904086
PMCPMC3526265
OpenAlexW2096641950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.